5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Platelet Aggregation
Platelet aggregation is a crucial physiological process that plays a central role in hemostasis, the prevention of excessive bleeding, and wound healing. Platelets, small cell fragments in the blood, adhere to exposed collagen at the site of vascular injury. Upon activation, platelets release chemical signals that further attract and activate additional platelets. This cascade of events leads to the formation of a plug, or clot, effectively sealing the breach in the blood vessel. While platelet aggregation is essential for maintaining vascular integrity, dysregulation of this process can contribute to pathological conditions, such as thrombosis or excessive clotting. Understanding the mechanisms behind platelet aggregation is fundamental not only for unraveling the complexities of hemostasis but also for developing therapeutic strategies to manage cardiovascular diseases and related disorders.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain